| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.8M | -32.0% | +10.2% |
| Cost of Revenue | $2.6M | -32.8% | +4.9% |
| Gross Profit | $1.2M | -30.4% | +24.5% |
| R&D Expense | $47K | -2.1% | +0.0% |
| SG&A Expense | $1.1M | +21.3% | +9.3% |
| Operating Income | -$408K | -216.6% | +27.3% |
| Net Income | -$388K | -176.2% | +26.4% |
| EPS (Basic) | -$0.04 | -180.0% | +20.0% |
| EPS (Diluted) | -$0.04 | -180.0% | +20.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $962K | -47.7% | +28.4% |
| Inventory | $3.1M | +79.2% | +45.2% |
| Current Assets | $8.1M | -17.7% | -3.1% |
| Total Assets | $9.5M | -16.1% | -5.7% |
| Current Liabilities | $3.7M | -27.4% | -3.6% |
| Total Liabilities | $4.5M | -24.5% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.8M | -979.0% | — |
| -7.8% |
| Stockholders' Equity | $5.0M | -7.0% | -3.8% |